Stanford University · BiologyDodd Lab
Dylan Dodd · Stanford, California
Research Focus
Dylan Dodd's lab at Stanford University focuses on harnessing gut microbiota to develop probiotics that can help treat genetic metabolic disorders, like Phenylketonuria (PKU). By understanding how gut bacteria influence human metabolism, the lab aims to create innovative therapies that utilize these beneficial microbes to control metabolic pathways. Their long-term goal is to lay the groundwork for new approaches to treat various inborn errors of metabolism.
microbiotaprobioticsinborn errors of metabolismPhenylketonuriametabolic pathways
Research Aims
2AIM 01Identify and characterize anaerobic pathways for phenylalanine metabolism by gut bacteria.
AIM 02Assess the ability of microbial pathways to reduce plasma phenylalanine levels in a gnotobiotic mouse model of PKU.
Skills the Lab Values
gene clusteringtranscriptomicsmetabolomicsgnotobiotic mouse modelsmicrobial genetics
Output against the department
Publications77bottom 22% of dept.801st of 1,033
this lab
most publishedleast published
Citations5.9kbottom 43% of dept.590th of 1,033
this lab
most citedleast cited
Career totals from OpenAlex, compared against labs that share a department. A department spans everything from one paper to tens of thousands, so bar heights are on a log scale — otherwise the largest lab would flatten every other bar to a line.